Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612660 · ClinicalTrials.gov registry record · NA
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT04612660: Completed NA study, sponsored by Temple University.
NCT04612660 is a NA study that has completed, run by Temple University. The registered enrollment target is 156 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04612660, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the preventable infection-related cervical cancer.
Interventions
- BEHAVIORAL Patient Navigation
- BEHAVIORAL General Health Education
- BEHAVIORAL Education on cervical cancer prevetnion
- BEHAVIORAL Dynamic group interaction
- BEHAVIORAL Physician engagement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT04612660 record still lists
NCT04612660 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which Patient Navigation is the first listed.
NCT04612660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04612660 about?
NCT04612660 is a clinical study titled "HPV Self-test to Increase Cervical Cancer Screening in Asian Women". The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the prev...
What is the current status of trial NCT04612660?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2014-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT04612660?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), General Health Education (BEHAVIORAL), Education on cervical cancer prevetnion (BEHAVIORAL), Dynamic group interaction (BEHAVIORAL), Physician engagement (BEHAVIORAL).
Who is sponsoring clinical trial NCT04612660?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04612660's enrollment target sits among peer trials
156 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia